Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-033805
Filing Date
2015-04-13
Accepted
2015-04-13 17:13:22
Documents
1
Period of Report
2015-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3950
  Complete submission text file 0001209191-15-033805.txt   5325
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDIVATION, INC. 201 SPEAR ST., 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 15767317